ATRO Medical
ATRO Medical's Artimis Meniscus Prosthesis reduces pain and restores mobility for patients suffering from chronic pain after loss of their meniscus. The solution is with a minimally invasive, low-impact surgery that preserves the knee joint and reduces KOA-related healthcare costs significantly. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€10m (Public information from Jun 2024)
Company register number 66544475
Nijmegen Gelderland (HQ & founding location)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Spinout | |
$3.4m | Seed | ||
$1.0m | Seed | ||
€340k | Grant | ||
* | €1.9m | Early VC | |
€2.5m | Grant | ||
N/A | Early VC | ||
| N/A | €600k | - | |
| Total Funding | €9.3m | ||
Related Content
Recent News about ATRO Medical
EditMore about ATRO Medical
EditDeveloper of a meniscus prosthesis designed to replace the damaged meniscus with an implantable prosthesis. The company's prosthesis is a synthetic, non-resorbable substitute that mimics the function of the natural meniscus and functions as a shock absorber by adequate load distribution within the knee joint, enabling osteoarthritis patients to get relief from severe pain and improve life.
Keywords: Healthcare Devices, Services, Supplies, Knee Arthroscopy, Meniscus Implants, Meniscus Prosthesis, Meniscus Replacement, Osteoarthritis Patients Treatment, Osteoarthritis Treatment Device.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.